telehealth

Hims & Hers reports Q1 earnings May 11 after settling patent dispute with Novo Nordisk, gaining rights to sell Wegovy and Ozempic while discontinuing compounded alternatives.

Mobile Health Network shares surge 21% after announcing $119M framework to acquire BIMA and M&M Helix, expanding AI healthcare services across Asia and Africa.

Enhanced Group debuts on NYSE emphasizing its clinical-backed performance medicine platform over gaming, positioning telehealth and peptide services as core growth driver versus competitors like Hims & Hers.

Amazon launches GLP-1 weight management program through One Medical, leveraging its healthcare ecosystem and logistics capabilities to tap into a market projected to reach nearly $100 billion by 2030.

U.S. behavioral health market valued at $101.84B in 2026, projected to reach $159.35B by 2035 at 5.1% annual growth amid rising mental health disorder prevalence.

Hims & Hers exploits GLP-1 and estrogen patch shortages, securing steady inventory to position itself as critical pharmaceutical supply anchor amid three-year supply constraints.

Teva Pharmaceuticals and Direct Relief fund mental health expansion at 11 free clinics across Alabama, Mississippi, and Texas, reaching 57,000 patients.

MISTR CEO joins Titanique Broadway production team, launching integrated campaigns combining theatrical marketing with PrEP awareness across multiple venues.

Telehealth performance medicine company Maximus ranks #7 on Financial Times' fastest-growing firms, driven by explosive revenue growth across testosterone, GLP-1, and peptide therapies.

Novo Nordisk launches Wegovy subscription program with monthly pricing from $249-$329, offering up to $1,200 annual savings via telehealth partners.

JD Health posts 23% revenue growth to 73.4B yuan with record 8.9% profit margin, but faces intensifying AI competition from Alibaba Health, Meituan, and others.

BLKBRD Asset Management fully exits $18M Hims & Hers position in Q4 2025, just before company reconciles with Novo Nordisk.

Universal Health Services to acquire Talkspace for $5.25/share in $835M deal, expanding virtual therapy access through 6,000 licensed professionals.

Cellhub launches AI-powered virtual care platform targeting 46% of rural hospitals operating at losses, combining 5G connectivity and managed services to address healthcare access crisis.

Online therapy market projected to grow from $4.38B (2025) to $17.34B (2035) at 14.76% CAGR, driven by mental health awareness and AI-enabled telehealth platforms.

Hims & Hers stock plunged 70% as GLP-1 market competition intensifies and growth slows. Despite challenges, company projects $2.8B 2026 revenue from diversified services.

Global ophthalmic drug market projected to reach $41.88B by 2026, growing 7.9% annually driven by biologic therapies, advanced delivery systems, and AI-enabled diagnostics.

Hims stock down 75% due to Novo Nordisk lawsuit over semaglutide marketing, but analysts see 150% upside potential and record revenue coming.

Grief counseling market projected to grow from $3.67B to $5.83B by 2030, driven by digital health expansion and increased mental health awareness.

Remote patient monitoring market projected to grow from $36.6B (2026) to $164.5B (2035) at 18.18% annual growth, driven by chronic disease prevalence and aging populations.